Meet the CENTOGENE team at the 3rd Annual Gene Therapy for Muscular Disorders Summit! Uniting the leading minds working across vector development, immunogenicity, and preclinical and clinical trials for muscular gene therapies, this summit is the only industry-led event focused specifically on overcoming the challenges associated with progressing gene therapies for muscular disorders that target the muscle cells themselves.
The summit brings together over 100 experts from leading companies and institutions committed to delivering transformative genetic therapies for Duchenne Muscular Dystrophy (DMD), Limb-Girdle Muscular Dystrophies, Myotubular Myopathies, and countless others targeting skeletal muscle to reverse disease progression and improve patient quality of life.
Arrange an in-person meeting to learn how CENTOGENE can help you overcome the specific challenges of developing safe, effective gene therapies that target muscle cells.